Altis Biosystems

Altis Biosystems, a spin-out from the University of North Carolina at Chapel Hill, is based in Durham, North Carolina. The company focuses on pioneering stem cell platform technology, specifically designed to replicate the human gut. Their core mission is to enable pharmaceutical companies to identify effective compounds earlier in the drug development process, thereby reducing animal testing and making the process faster, cheaper, and safer. Altis Biosystems offers the RepliGut® Planar model, a reproducible and scalable human intestine platform suitable for studying various aspects of drug disposition.

Notable affiliated individuals include researchers and scientists from the University of North Carolina at Chapel Hill who contributed to the development of the company's intellectual property. Altis Biosystems has received significant recognition for its innovative approach, including an NIH Transformative Research Award. The company's impact is evident in its potential to revolutionize drug development by providing more accurate early-stage testing models, ultimately improving the efficiency and safety of new pharmaceuticals.